1. Home
  2. Clinical Topics
  3. FDA approves first treatment for Erdheim-Chester Disease
Clinical TopicsDrugs and DevicesWeb Exclusives
fda treatment erdheim chester disease cancer blood

FDA approves first treatment for Erdheim-Chester Disease

Share

On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. Read more via Fda.gov.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts